Bavarian consortium for research on the pandemic disease COVID-19 (FOR-COVID)

Active and passive immunization, analysis of the human immune response

The broad use of protective vaccines is the only option to efficiently halt the global suffering caused by SARS-CoV-2 infection. Therefore, continuous advancements in the design and continued development of vaccines are needed to combat the ongoing pandemic.
Additionally, a profound knowledge of the breadth and durability of SARS-CoV-2 specific immune responses after viral infection as well a after vaccination is essential to address the pandemic. 
With the considerable evolution of SARS-CoV-2 and the emergence of VoCs it will be of special significance to characterize the mutations and their impact in the efficacy of vaccines, transmissibility and immune escape.



Launching date